Urgent U.S. recall issued for Global Pharma Healthcare eye drops

[Image courtesy of ezricare-info.com]

Global Pharma Healthcare is voluntarily recalling lubricant eye drops owing to potential contamination. The recall is a result of an investigation by the Centers for Disease Control and Prevention (CDC) into a cluster of multi-state infections linked to the use of the product.

CDC suspects that a cluster of Verona Integron-mediated Metallo-β-lactamase (VIM)- and Guiana-Extended Spectrum-β-Lactamase (GES)- producing carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) infections are linked to the company’s eye drops.

An FDA notice states that the eye drops may cause serious adverse events, including eye infections, loss of vision and even death.

55 reports of adverse advents

There have been 55 reports of adverse events associated with the eye drops, including eye infections, permanent vision loss and a death associated with a bloodstream infection…

Read more
  • 0